JP2014517078A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014517078A5 JP2014517078A5 JP2014517231A JP2014517231A JP2014517078A5 JP 2014517078 A5 JP2014517078 A5 JP 2014517078A5 JP 2014517231 A JP2014517231 A JP 2014517231A JP 2014517231 A JP2014517231 A JP 2014517231A JP 2014517078 A5 JP2014517078 A5 JP 2014517078A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- disorder
- pharmaceutical composition
- composition according
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| USPCT/US2011/041866 | 2011-06-24 | ||
| PCT/US2011/041866 WO2012177263A1 (en) | 2011-06-24 | 2011-06-24 | Compounds and methods of prophylaxis and treatment regarding nictonic receptor antagonists |
| US201161501207P | 2011-06-25 | 2011-06-25 | |
| US61/501,207 | 2011-06-25 | ||
| PCT/US2012/043880 WO2012178112A1 (en) | 2011-06-24 | 2012-06-22 | Organic compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014517078A JP2014517078A (ja) | 2014-07-17 |
| JP2014517078A5 true JP2014517078A5 (enExample) | 2015-10-01 |
| JP6087911B2 JP6087911B2 (ja) | 2017-03-01 |
Family
ID=47422974
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014517231A Active JP6087911B2 (ja) | 2011-06-24 | 2012-06-22 | 有機化合物 |
Country Status (13)
| Country | Link |
|---|---|
| US (4) | US9469625B2 (enExample) |
| EP (1) | EP2723173B1 (enExample) |
| JP (1) | JP6087911B2 (enExample) |
| KR (1) | KR20140036305A (enExample) |
| CN (1) | CN103717069B (enExample) |
| AU (2) | AU2012272680A1 (enExample) |
| BR (1) | BR112013033306A2 (enExample) |
| CA (2) | CA2840047A1 (enExample) |
| ES (1) | ES2627338T3 (enExample) |
| IL (1) | IL230036A (enExample) |
| MX (1) | MX342322B (enExample) |
| RU (1) | RU2610094C2 (enExample) |
| WO (3) | WO2012177263A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012177263A1 (en) * | 2011-06-24 | 2012-12-27 | Intra-Cellular Therapies, Inc. | Compounds and methods of prophylaxis and treatment regarding nictonic receptor antagonists |
| US11491150B2 (en) | 2017-05-22 | 2022-11-08 | Intra-Cellular Therapies, Inc. | Organic compounds |
| WO2019152680A1 (en) * | 2018-01-31 | 2019-08-08 | Flagship Pioneering Innovations V, Inc. | Methods and compositions for treating cancer using chrna6 inhibitors |
| WO2020146384A1 (en) | 2019-01-07 | 2020-07-16 | Intra-Cellular Therapies, Inc. | Organic compounds |
| WO2021008565A1 (zh) * | 2019-07-16 | 2021-01-21 | 清华大学 | 乙酰胆碱通路调节剂在治疗癌症中的用途 |
| EP4238970A1 (en) * | 2022-03-03 | 2023-09-06 | InterAx Biotech AG | Modulators of ackr3 and uses thereof |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6953855B2 (en) * | 1998-12-11 | 2005-10-11 | Targacept, Inc. | 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| PE20021019A1 (es) * | 2001-04-19 | 2002-11-13 | Upjohn Co | Grupos azabiciclicos sustituidos |
| ES2338539T3 (es) * | 2001-11-01 | 2010-05-10 | Icagen, Inc. | Pirazolamidas para uso en el tratamiento del dolor. |
| BR0315056A (pt) | 2002-11-01 | 2005-08-16 | Pharmacia & Upjohn Co Llc | Compostos tendo tanto atividade agonista nicotìnica de alfa7 quanto atividade antagonista de 5ht3 para o tratamento de doenças do sistema nervoso central |
| MXPA05007689A (es) * | 2003-01-22 | 2005-09-30 | Pharmacia & Upjohn Co Llc | Tratamiento de enfermedades con agonistas completos del receptor alfa-7 de nach. |
| US7135575B2 (en) * | 2003-03-03 | 2006-11-14 | Array Biopharma, Inc. | P38 inhibitors and methods of use thereof |
| JP2006525355A (ja) * | 2003-05-01 | 2006-11-09 | アボット・ラボラトリーズ | ナトリウムチャンネルモジュレーターとしてのピラゾール−アミドおよびスルホンアミド |
| US20040220170A1 (en) * | 2003-05-01 | 2004-11-04 | Atkinson Robert N. | Pyrazole-amides and sulfonamides as sodium channel modulators |
| EP1638944A1 (en) * | 2003-06-12 | 2006-03-29 | Eli Lilly And Company | Tachykinin receptor antagonists |
| WO2009112459A1 (en) | 2008-03-11 | 2009-09-17 | Neurosearch A/S | Novel 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors |
| US20100179186A1 (en) | 2008-10-10 | 2010-07-15 | University Of Kentucky Research Foundation | USE OF A NOVEL ALPHA-7 nAChR ANTAGONIST TO SUPPRESS PATHOGENIC SIGNAL TRANSDUCTION IN CANCER AND AIDS |
| WO2012177263A1 (en) | 2011-06-24 | 2012-12-27 | Intra-Cellular Therapies, Inc. | Compounds and methods of prophylaxis and treatment regarding nictonic receptor antagonists |
-
2011
- 2011-06-24 WO PCT/US2011/041866 patent/WO2012177263A1/en not_active Ceased
-
2012
- 2012-06-22 CA CA2840047A patent/CA2840047A1/en not_active Abandoned
- 2012-06-22 US US14/128,378 patent/US9469625B2/en active Active
- 2012-06-22 AU AU2012272680A patent/AU2012272680A1/en not_active Abandoned
- 2012-06-22 ES ES12802484.1T patent/ES2627338T3/es active Active
- 2012-06-22 WO PCT/US2012/043813 patent/WO2012178057A1/en not_active Ceased
- 2012-06-22 KR KR1020147000636A patent/KR20140036305A/ko not_active Withdrawn
- 2012-06-22 CA CA2840373A patent/CA2840373A1/en not_active Abandoned
- 2012-06-22 JP JP2014517231A patent/JP6087911B2/ja active Active
- 2012-06-22 EP EP12802484.1A patent/EP2723173B1/en active Active
- 2012-06-22 RU RU2014102191A patent/RU2610094C2/ru not_active IP Right Cessation
- 2012-06-22 US US14/127,699 patent/US9108949B2/en active Active
- 2012-06-22 BR BR112013033306A patent/BR112013033306A2/pt not_active IP Right Cessation
- 2012-06-22 MX MX2014000255A patent/MX342322B/es active IP Right Grant
- 2012-06-22 WO PCT/US2012/043880 patent/WO2012178112A1/en not_active Ceased
- 2012-06-22 AU AU2012272646A patent/AU2012272646B2/en not_active Ceased
- 2012-06-22 CN CN201280035785.5A patent/CN103717069B/zh active Active
-
2013
- 2013-12-19 IL IL230036A patent/IL230036A/en active IP Right Grant
-
2015
- 2015-06-17 US US14/742,570 patent/US9452160B2/en active Active
-
2016
- 2016-01-11 US US14/993,048 patent/US9708294B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014517078A5 (enExample) | ||
| JP2014500295A5 (enExample) | ||
| JP2014517050A5 (enExample) | ||
| JP2017528487A5 (enExample) | ||
| AU2014220377B2 (en) | Treatment of graft versus host disease in transplant patients | |
| JP2019515908A5 (enExample) | ||
| JP2014513705A (ja) | 進行性固形腫瘍の治療方法 | |
| RU2014102191A (ru) | Органические соединения | |
| CN110198716A (zh) | 癌症治疗 | |
| RU2020108192A (ru) | Терапевтическая комбинация ингибитора тирозинкиназы egfr третьего поколения и ингибитора raf | |
| JP2021113228A (ja) | 重度腎機能障害を有する癌患者に対する治療方法 | |
| CN106632383A (zh) | 莪术醇衍生物及其制备方法和在抗肿瘤药物中的应用 | |
| JP2018525447A5 (enExample) | ||
| de Rouw et al. | Pharmacokinetically-guided dosing of pemetrexed in a patient with renal impairment and a patient requiring hemodialysis | |
| WO2025167738A1 (zh) | 化合物在制备治疗非髓系恶性肿瘤患者的贫血药物中的应用 | |
| US9376432B2 (en) | Use of VEGFR-3 inhibitors for treating hepatocellular carcinoma | |
| Kizior et al. | Saunders Nursing Drug Handbook 2026-E-Book | |
| Yu et al. | OA03. 04 efficacy and safety of the novel HER3 directed antibody drug conjugate patritumab deruxtecan (HER3-DXd; U3-1402) in EGFR-mutated NSCLC | |
| JP2018506534A5 (enExample) | ||
| JP2020530851A5 (enExample) | ||
| Nakamura et al. | OA03. 05 Phase III Study Comparing Nab-Paclitaxel With Docetaxel in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer | |
| Park et al. | C1-07: IPI-504, a novel HSP90 inhibitor is effective in EGFR T790M and Non-T790M Gefitinib-resistant Lung Cancer Cell Lines. | |
| Jones | Chloroquine and quinine | |
| HK40096869A (zh) | 结晶5-(二甲基氨基)-n-(4-(吗啉代甲基)苯基)萘-1-磺酰胺二盐酸盐二水合物 | |
| JP2013544844A5 (enExample) |